Related Experiment Video
Updated: Dec 24, 2025

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
Published on: May 5, 2020
Ischemic Heart Disease: An Update
Rebekka Vibjerg Jensen1, Marie Vognstoft Hjortbak1, Hans Erik Bøtker1
1Department of Cardiology, Aarhus University Hospital, Aarhus N, Denmark.
Insights
Ischemic heart disease management is evolving with new diagnostic tools like coronary CT angiography and functional imaging. Optimal medical treatment and FFR-guided revascularization improve outcomes for patients with coronary artery disease.
Area of Science:
- Cardiology
- Medical Imaging
- Atherosclerosis Research
Background:
- Ischemic heart disease (IHD) involves coronary artery atherosclerosis or functional circulation changes.
- IHD management includes lifestyle changes, medications, and revascularization, potentially stabilizing or regressing the disease.
- New classifications distinguish between acute coronary syndrome and chronic coronary syndrome.
Purpose of the Study:
- To review current diagnostic and treatment strategies for ischemic heart disease.
- To highlight the role of noninvasive imaging in diagnosing coronary artery disease.
- To emphasize the importance of optimal medical treatment and FFR-guided revascularization.
Main Methods:
- Review of current literature and clinical guidelines for ischemic heart disease diagnosis and management.
- Focus on noninvasive imaging modalities such as coronary computed tomography (CT) angiography.
- Discussion of functional assessments including nuclear, MRI, and CT-based fractional flow reserve (FFR-CT).
Main Results:
- Coronary CT angiography is a first-line diagnostic tool in suitable patients, offering high diagnostic accuracy.
- Noninvasive functional or anatomic imaging is recommended for symptomatic patients when obstructive disease is suspected.
- FFR-guided myocardial revascularization offers symptom relief and prognostic benefits for non-responsive patients.
Conclusions:
- Optimal medical treatment is crucial for managing ischemic heart disease.
- Advanced noninvasive imaging, particularly coronary CT angiography with FFR-CT, enhances diagnostic capabilities.
- Personalized treatment strategies, including FFR-guided revascularization, improve patient outcomes and reduce myocardial infarction risk.
Abstract:
Ischemic heart disease is a dynamic process of atherosclerosis of the coronary arteries or functional alterations of coronary circulation that can be modified by lifestyle, pharmacological therapies, and revascularization. Such treatment may result in disease stabilization or regression. New terminology describes clinical presentations of Ischemic heart disease categorized as either acute coronary syndrome or chronic coronary syndrome. The reduction in prevalence of obstructive coronary artery disease in a symptomatic population causes a lower pretest probability and clinical likelihood of disease, influencing the diagnostic work-up. Noninvasive functional or anatomic imaging for myocardial ischemia is recommended as the initial test to diagnose coronary artery disease in symptomatic patients, where obstructive disease cannot be excluded by clinical assessment alone. Coronary computed tomography (CT) angiography has advanced and is first line in suitable patients, due to high rule-out power and further qualification of the diagnosis by functional assessment using noninvasive nuclear or magnetic resonance technology or CT-based fractional flow reserve (FFR-CT). Optimal medical treatment remains paramount, while FFR-guided myocardial revascularization in patients that are not responsive to antianginal treatment provides further symptom relieve as well as prognostic impact on prevention of spontaneous myocardial infarction.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease II: Pathophysiology
Cardiomyopathy V: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Rheumatic Heart Disease III: Medical Management

